SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-08-000369
Filing Date
2008-05-14
Accepted
2008-05-14 13:36:36
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a40842e10vq.htm 10-Q 440019
2 EXHIBIT 10.1 a40842exv10w1.htm EX-10.1 186558
3 EXHIBIT 31.1 a40842exv31w1.htm EX-31.1 6732
4 EXHIBIT 31.2 a40842exv31w2.htm EX-31.2 7015
5 EXHIBIT 32.0 a40842exv32w0.htm EX-32.0 3562
  Complete submission text file 0000936392-08-000369.txt   645409
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 08830801
SIC: 2834 Pharmaceutical Preparations